Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles

Ameet Sarpatwari, J.D., Ph.D.

Title
Institution
Department
Address
Phone
Other Positions
Title
Institution
Department

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly J, Fischer MA, Kesselheim AS, Gagne JJ. Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study. BMJ. 2018 Apr 03; 361:k1180. PMID: 29615391.
    View in: PubMed
  2. Fuse Brown EC, Sarpatwari A. Removing ERISA's Impediment to State Health Reform. N Engl J Med. 2018 Jan 04; 378(1):5-7. PMID: 29298152.
    View in: PubMed
  3. Sarpatwari A, Gluck AR, Curfman GD. The Supreme Court Ruling in Sandoz v Amgen: A Victory for Follow-on Biologics. JAMA Intern Med. 2018 Jan 01; 178(1):5-6. PMID: 29131908.
    View in: PubMed
  4. Curfman GD, Beletsky L, Sarpatwari A. Benefits, Limitations, and Value of Abuse-Deterrent Opioids. JAMA Intern Med. 2018 Jan 01; 178(1):131-132. PMID: 29228102.
    View in: PubMed
  5. Sarpatwari A, Lee MP, Gagne JJ, Lu Z, Dutcher SK, Jiang W, Campbell EG, Kesselheim AS. Generic Versions of Narrow Therapeutic Index Drugs: A National Survey of Pharmacists' Substitution Beliefs and Practices. Clin Pharmacol Ther. 2017 Nov 22. PMID: 29165800.
    View in: PubMed
  6. Vokinger KN, Kesselheim AS, Avorn J, Sarpatwari A. Strategies That Delay Market Entry of Generic Drugs. JAMA Intern Med. 2017 Nov 01; 177(11):1665-1669. PMID: 28975217.
    View in: PubMed
  7. Sarpatwari A, Choudhry NK. Recalibrating Privacy Protections to Promote Patient Engagement. N Engl J Med. 2017 Oct 19; 377(16):1509-1511. PMID: 29045208.
    View in: PubMed
  8. Hwang TJ, Kesselheim AS, Sarpatwari A. Value-Based Pricing and State Reform of Prescription Drug Costs. JAMA. 2017 08 15; 318(7):609-610. PMID: 28692713.
    View in: PubMed
  9. Wang B, Studdert DM, Sarpatwari A, Franklin JM, Landon J, Kesselheim AS. The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine. PLoS One. 2017; 12(4):e0175313. PMID: 28388667.
    View in: PubMed
  10. Sarpatwari A, Gagne JJ, Levidow NL, Kesselheim AS. Active Surveillance of Follow-on Biologics: A Prescription for Uptake. Drug Saf. 2017 02; 40(2):105-108. PMID: 27838823.
    View in: PubMed
  11. Kesselheim AS, Rome BN, Sarpatwari A, Avorn J. Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug Makers. Health Aff (Millwood). 2017 Feb 01; 36(2):362-370. PMID: 28100464.
    View in: PubMed
  12. Sarpatwari A, Avorn J, Kesselheim AS. Factors Influencing Prescription Drug Costs in the United States-Reply. JAMA. 2016 12 13; 316(22):2431-2432. PMID: 27959994.
    View in: PubMed
  13. Kesselheim AS, Avorn J, Sarpatwari A. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform. JAMA. 2016 Aug 23-30; 316(8):858-71. PMID: 27552619.
    View in: PubMed
  14. Yeh JS, Sarpatwari A, Kesselheim AS. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels. Drug Saf. 2016 08; 39(8):709-14. PMID: 27000800.
    View in: PubMed
  15. Sarpatwari A, Kesselheim AS. Navigating the Dermatological Drug Cost Curve. JAMA. 2016 Jun 28; 315(24):2724-5. PMID: 27367767.
    View in: PubMed
  16. Sarpatwari A, Avorn J, Kesselheim AS. State Initiatives to Control Medication Costs--Can Transparency Legislation Help? N Engl J Med. 2016 Jun 16; 374(24):2301-4. PMID: 27305189.
    View in: PubMed
  17. Sarpatwari A, Gagne JJ. Balancing benefits and harms: privacy protection policies. Pharmacoepidemiol Drug Saf. 2016 Aug; 25(8):969-71. PMID: 27278106.
    View in: PubMed
  18. Sarpatwari A, Kesselheim AS. Efficacy of the Priority Review Voucher Program. JAMA. 2016 Apr 19; 315(15):1660-1. PMID: 27092839.
    View in: PubMed
  19. Sarpatwari A, Kesselheim AS. The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry? PLoS Med. 2016 Feb; 13(2):e1001955. PMID: 26859662; PMCID: PMC4747525.
  20. Luo J, Sarpatwari A, Kesselheim AS. Regulatory Solutions to the Problem of High Generic Drug Costs. Open Forum Infect Dis. 2015 Dec; 2(4):ofv179. PMID: 26693494; PMCID: PMC4685151.
  21. Kesselheim AS, Maggs LR, Sarpatwari A. Experience With the Priority Review Voucher Program for Drug Development. JAMA. 2015 Oct 27; 314(16):1687-8. PMID: 26414802.
    View in: PubMed
  22. Sarpatwari A, Kesselheim AS. The 21st century cures act: Opportunities and challenges. Clin Pharmacol Ther. 2015 Dec; 98(6):575-7. PMID: 26264909.
    View in: PubMed
  23. Avorn J, Sarpatwari A, Kesselheim AS. Forbidden and Permitted Statements about Medications--Loosening the Rules. N Engl J Med. 2015 Sep 03; 373(10):967-73. PMID: 26332553.
    View in: PubMed
  24. Sarpatwari A, Avorn J, Kesselheim AS. Progress and Hurdles for Follow-on Biologics. N Engl J Med. 2015 Jun 18; 372(25):2380-2. PMID: 25946143.
    View in: PubMed
  25. Sarpatwari A, Darrow JJ, Kesselheim AS. Expanded access to investigational drugs. N Engl J Med. 2015 Apr 09; 372(15):1473-4. PMID: 25853762.
    View in: PubMed
  26. Sarpatwari A, Choudhry NK, Avorn J, Kesselheim AS. Paying physicians to prescribe generic drugs and follow-on biologics in the United States. PLoS Med. 2015 Mar; 12(3):e1001802. PMID: 25781468; PMCID: PMC4363899.
  27. Darrow JJ, Sarpatwari A, Avorn J, Kesselheim AS. Practical, legal, and ethical issues in expanded access to investigational drugs. N Engl J Med. 2015 Jan 15; 372(3):279-86. PMID: 25587952.
    View in: PubMed
  28. Sarpatwari A, Franklin JM, Avorn J, Seeger JD, Landon JE, Kesselheim AS. Are risk evaluation and mitigation strategies associated with less off-label use of medications? The case of immune thrombocytopenia. Clin Pharmacol Ther. 2015 Feb; 97(2):186-93. PMID: 25670524.
    View in: PubMed
  29. Sarpatwari A, Kesselheim AS, Malin BA, Gagne JJ, Schneeweiss S. Ensuring patient privacy in data sharing for postapproval research. N Engl J Med. 2014 Oct 23; 371(17):1644-9. PMID: 25337755.
    View in: PubMed
  30. Sarpatwari A, Avorn J, Kesselheim AS. Using a drug-safety tool to prevent competition. N Engl J Med. 2014 Apr 17; 370(16):1476-8. PMID: 24738666.
    View in: PubMed
  31. Anzures-Cabrera J, Sarpatwari A, Higgins JP. Expressing findings from meta-analyses of continuous outcomes in terms of risks. Stat Med. 2011 Nov 10; 30(25):2967-85. PMID: 21826697.
    View in: PubMed
  32. Sarpatwari A, Bussel JB, Ahmed M, Erqou S, Semple JW, Newland AC, Bennett D, Pharoah P, Provan D. Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults. Hematology. 2011 Jul; 16(4):243-8. PMID: 21756542.
    View in: PubMed
  33. Sarpatwari A, Provan D, Erqou S, Sobnack R, David Tai FW, Newland AC. Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry. Br J Haematol. 2010 Dec; 151(5):477-87. PMID: 20950403.
    View in: PubMed
  34. Sarpatwari A, Watson S, Erqou S, Anderson H, Grainger J, Higgins JP, Newland AC. Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP). Br J Haematol. 2010 Oct; 151(2):189-91. PMID: 20666773.
    View in: PubMed
  35. Sarpatwari A, Bennett D, Logie JW, Shukla A, Beach KJ, Newland AC, Sanderson S, Provan D. Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database. Haematologica. 2010 Jul; 95(7):1167-75. PMID: 20145266; PMCID: PMC2895042.
  36. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provan D, Newland A, Amadori S, Bussel JB. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009 Feb 05; 113(6):1231-40. PMID: 18945961.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu. SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Sarpatwari's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
Explore
_
Co-Authors
Explore
_
Similar People
Explore
_
Same Department 
Explore
_